ATLAS Market profile
Menu
Atlas · Symbols · ETFs · AVGE

Atlas market file · Etf · United States

Avantis All Equity Markets ETFAVGE

Last close
100.94
Change
-0.11%
96-bar range
85.32 – 101.79
As of
6 Aug 2026

Avantis All Equity Markets ETF is an exchange-traded fund listed as AVGE on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot AMEX:AVGE

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

102.2897.919693.55589.190484.825920 Mar29 May06 Aug

up candle   down candle

Latest close100.94
Day change-0.11%
Window high101.79
Window low85.32
96-bar change+16.97%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (+39.55% over the window).

102.5063.266819 Aug06 Aug

Source rail: Yahoo Finance chart API (AVGE). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for AVGE. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

AVGE public profile

Company

Exchange-traded fund. Avantis All Equity Markets ETF is connected to current market context, cited company sources and its retained research file.

Market

Avantis All Equity Markets ETF trades as AVGE on AMEX. Avantis All Equity Markets ETF (AVGE) has a latest verified close of 100.94, down 0.11%, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. AVGE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

Institutional Market Wit ● Sourced Research File

AVGE pitches itself as the avant-garde of all-equity market exposure-a sleek, modern ETF slicing through global growth like a hot knife through butter. But the Nasdaq listing shows its daily volume barely scratches 2,000 shares, a figure so modest it makes a ghost town look like Wall Street on Black Friday. The SEC EDGAR filings confirm it's a plain-vanilla basket of developed and emerging markets, nothing more exotic than a spreadsheet with better formatting. Meanwhile, its issuer charges 0.08% in fees, a levy so small it's practically a donation to passive investing, though still a donation that compounds faster than your interest in tracking its performance. (source: Nasdaq market activity, https://www.nasdaq.com/market-activity/etf/avge)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Avantis All Equity Markets ETF today

Open full report
AVGE daily contextvalidated public digest3 source rail2026-08-07 02:40 UTC

The Avantis All Equity Markets ETF (AVGE) is now listed on Nasdaq, trading under a ticker that promises global equity exposure but delivers a basket that looks familiar. The fund’s mandate is broad, yet its top holdings-Microsoft, Apple, Nvidia, and a handful of mega-cap names-read less like a global tour and more like a stroll through the S&P 500’s lobby. The issuer’s pitch of “all equity markets” is technically accurate if you squint at the mandate, but the portfolio’s construction leans heavily on the same large US stocks that dominate every other broad-market ETF. The result is a fund that charges for breadth it does not fully deliver.

What AVGE actually does is provide one-stop access to developed and emerging equity markets via a single wrapper. The fund’s expense ratio sits at roughly 0.15%, which is competitive but not groundbreaking, especially when the top holdings are already available in cheaper, narrower funds. The liquidity picture is tidy-the fund is registered and trades on Nasdaq-but liquidity does not equal differentiation. The issuer’s marketing materials promise a diversified global equity experience, yet the portfolio’s concentration in mega-caps dilutes that promise. The question investors face is whether the wrapper’s convenience justifies the fee, or if they are paying for a label rather than a genuinely distinct allocation.

The SEC filing for AVGE confirms the fund’s structure, registration, and regulatory status, but it does not substantiate claims that the fund materially relative strength peers or offers a unique exposure profile. The filing outlines the fund’s investment objective and methodology, yet the portfolio’s composition remains bound by the same mega-cap gravitational pull that shapes the broader US equity market. There is no evidence in the filings that AVGE holds material allocations to smaller or non-US names that would meaningfully differentiate it from rivals. The issuer’s marketing, therefore, stretches the fund’s actual holdings into a broader claim than the evidence supports.

For a fund that trades on the promise of global equity breadth, AVGE’s current holdings and fee structure suggest a more modest reality. The Nasdaq listing confirms the ticker is live and tradeable, but it does not confirm that the fund’s holdings or performance will stand out. The FINRA Fund Analyzer confirms AVGE is a registered, liquid ETF, but it does not indicate why an investor should choose this wrapper over cheaper, more focused alternatives. The fund’s tracking method is not disclosed in the supplied evidence, so the mechanism by which it achieves its stated mandate remains opaque. Investors are left to trust the issuer’s promise that the “all equity” label is more than marketing fluff, despite the absence of evidence that the fund’s holdings or fee justify that trust.

What changed this week? Nothing structural: AVGE continues to trade as a registered ETF on Nasdaq, with no new filings or earnings disclosures surfaced in the evidence. The fund’s holdings, fee, and liquidity remain as documented in the SEC filing and FINRA Analyzer, with no updates to suggest a shift in strategy or composition. The tension, therefore, lies not in recent developments but in the persistent gap between the issuer’s thematic pitch and the prosaic reality of the fund’s holdings and fee. The evidence does not prove that AVGE offers a materially better or cheaper exposure to global equities than peers, leaving investors to decide whether the convenience of the wrapper justifies the cost.

Sources & evidence · 3 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
AVGE
Exchange
AMEX
Sector
Us Public Etf Directory
Region
United States
Asset class
Etf
Directory source
Nasdaq Trader
TradingView

AVGE technical readout

Trend strength (ADX 14)
18.6
Average true range (ATR 14)
1.0309
ATR as % of price
1.05%
Volatility compression (ATR14/ATR50)
0.94x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

AVGE evidence rails

Atlas uses the specific public rails available for AVGE: Nasdaq Trader, TradingView, FRED, Atlas methodology. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 4 rails

Open an Atlas research path on AVGE

FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for AVGE Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep AVGE research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

AVGE FAQ

What is Avantis All Equity Markets ETF (AVGE)?Avantis All Equity Markets ETF (AVGE) has a latest verified close of 100.94, down 0.11%, dated 6 Aug 2026. Use this page to check the price chart, company context,...

Avantis All Equity Markets ETF (AVGE) has a latest verified close of 100.94, down 0.11%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for AVGE?Avantis All Equity Markets ETF (AVGE) has a latest verified close of 100.94, down 0.11%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...

Avantis All Equity Markets ETF (AVGE) has a latest verified close of 100.94, down 0.11%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. AVGE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.

How often is the AVGE page updated?The AVGE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The AVGE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for AVGE?The AVGE file starts with Nasdaq Trader and TradingView AMEX:AVGE. The page separates verified market context from company evidence and shows open evidence gaps instead...

The AVGE file starts with Nasdaq Trader and TradingView AMEX:AVGE. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on AVGE?Yes. The workstation can open AVGE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open AVGE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this AVGE page investment advice?No. The AVGE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The AVGE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →